20 20 Optimeyes Technologies
Conventional treatments for eye diseases such as Glaucoma and Dry Eye Disease are insufficient- they require frequent dosing (multiple times a day for some meds), can be painful to dose and patient compliance can be as low as 50%. The goal of 20/20 OptimEyes Technologies is to use our proprietary micelle platform technology to better control the release of drugs. This will allow for prolonged drug penetration into the eye, meaning patients can use a comfortable drop only once or twice per week.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at 20 20 Optimeyes Technologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at 20 20 Optimeyes Technologies
1 distinct titles indexed · top 1 shown.
- 1chief innovation officer
Sign up to unlock all 1 contacts at 20 20 Optimeyes Technologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at 20 20 Optimeyes Technologies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.